CLPT trades 48.8% below Wall Street's consensus target of $23.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CLPT achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 23, 2026, ClearPoint Neuro, Inc. (CLPT) has a Wall Street consensus price target of $23.50, based on estimates from 3 covering analysts. With the stock currently trading at $15.79, this represents a potential upside of +48.8%. The company has a market capitalization of $474M.
Analyst price targets range from a low of $22.00 to a high of $25.00, representing a 13% spread in expectations. The median target of $23.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CLPT trades at a trailing P/E of -17.5x. Analysts expect EPS to grow -12.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NVCRNovocure Ltd | $1.9B | $16.67 | $26.00 | +56.0% | Buy | — | 15 |
 INVAInnoviva, Inc. | $1.5B | $20.98 | $38.00 | +81.1% | Buy | 8.5x | 10 |
 ABTAbbott Laboratories | $180.7B | $103.73 | $121.50 | +17.1% | Buy | 18.8x | 41 |
 MDTMedtronic plc | $116.5B | $90.77 | $98.00 | +8.0% | Buy | 15.2x | 51 |
 ANGOAngioDynamics, Inc. | $648M | $15.67 | $19.50 | +24.4% | Hold | — | 11 |
 ATECAlphatec Holdings, Inc. | $1.6B | $10.33 | $16.22 | +57.0% | Buy | 31.6x | 20 |
 GEGE Aerospace | $331.2B | $319.22 | $411.60 | +28.9% | Buy | 40.3x | 35 |
 GEHCGE HealthCare Technologies Inc. | $29.9B | $66.27 | $78.73 | +18.8% | Buy | 13.5x | 18 |
 SYKStryker Corporation | $105.5B | $275.07 | $372.39 | +35.4% | Buy | 18.3x | 52 |
 ISRGIntuitive Surgical, Inc. | $142.0B | $402.09 | $491.15 | +22.1% | Buy | 37.2x | 57 |
Quick answers to the most common questions about buying CLPT stock.
The consensus Wall Street price target for CLPT is $23.5, representing 48.8% upside from the current price of $15.79. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CLPT has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $23.5 implies 48.8% upside from current levels.
CLPT's current price is $15.79 with a consensus target of $23.5 (48.8% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $25 for CLPT, while the most conservative target is $22. The consensus of $23.5 represents the median expectation. These targets typically reflect 12-month expectations.
CLPT is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLPT stock forecast based on 3 Wall Street analysts shows a consensus price target of $23.5, with estimates ranging from $22 (bear case) to $25 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on CLPT, with a "Buy" consensus rating and $23.5 price target (48.8% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLPT analyst price targets range from $22 to $25, a 13% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $23.5 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.